NCT02367820 2021-06-22
SUMMIT-LTS
Nektar Therapeutics
Phase 3 Completed
Clinical Trials
6 trialsNCT01789216 2021-02-03
PAIN
Major Extremity Trauma Research Consortium
Phase 3 Completed
NCT02408393 2019-07-10
MIRs03
Institut Curie
Phase 3 Completed
NCT02603705 2018-03-05
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
Egalet Ltd
Phase 3 Completed
NCT00410748 2010-04-27
Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)
Alza Corporation, DE, USA
Phase 3 Completed
NCT00911261 2010-02-15
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
Endo Pharmaceuticals
Phase 3 Completed